Trx-8mer-OVX313

N/A

Report date: 2025/01/26 16:48:49

Base Information

Drug NameTrx-8mer-OVX313
Drug Alias NameHPV vaccine(DKFZ/Osivax)thermostable thioredoxin-L2 multiepitope nanoparticle HPV vaccine (Deutsches Krebsforschungszentrum)thioredoxin L2 polytope antigen fused to heptamerization domain (DKFZ German Cancer Research Cente)PfTrx–8-mer–OVX313PfTrx-L2(8x)-OVX313
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Inactivated vaccine > Subunit vaccineBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsPapillomavirus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesGerman Cancer Research Center (Dkfz)
China Registration ClassN/A

Develop Information

Active CompaniesOsivax SasGerman Cancer Research Center (Dkfz)
Inactive CompaniesN/A
Active IndicationsPapillomavirus Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A